Nabriva Therapeutics plc Earnings Per Share (Diluted)
Nabriva Therapeutics plc reported Earnings Per Share (Diluted) of -$3.73 per share for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2023-10-19
- Nabriva Therapeutics plc earnings per share, diluted for the quarter ending 2023-06-30 was -$3.73.
- Nabriva Therapeutics plc earnings per share, diluted for the quarter ending 2023-03-31 was -$2.72.
- Nabriva Therapeutics plc earnings per share, diluted for the quarter ending 2022-09-30 was -$4.21.
- Nabriva Therapeutics plc earnings per share, diluted for the quarter ending 2022-06-30 was -$4.38.
- Nabriva Therapeutics plc earnings per share, diluted for fiscal 2022 was -$21.32.
- Nabriva Therapeutics plc earnings per share, diluted for fiscal 2021 was -$28.52.
- Nabriva Therapeutics plc earnings per share, diluted for fiscal 2020 was -$135.23.
- Nabriva Therapeutics plc earnings per share, diluted for fiscal 2019 was -$11.15.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$3.73 10-Q · filed 2023-10-19 | -$6.43 10-Q · filed 2023-10-19 | ||||||
| 2023-03-31 | -$2.72 10-Q · filed 2023-05-22 | |||||||
| 2022-12-31 | -$21.32 10-K · filed 2023-04-17 | |||||||
| 2022-09-30 | -$4.21 10-Q · filed 2022-11-10 | -$13.55 10-Q · filed 2022-11-10 | ||||||
| 2022-06-30 | -$4.38 10-Q · filed 2023-10-19 | -$0.18 10-Q · filed 2022-08-03 | -$9.38 10-Q · filed 2023-10-19 | -$0.38 10-Q · filed 2022-08-03 | ||||
| 2022-03-31 | -$5.03 10-Q · filed 2023-05-22 | -$0.20 10-Q · filed 2022-05-05 | ||||||
| 2021-12-31 | -$28.52 10-K · filed 2023-04-17 | -$1.14 10-K · filed 2022-03-29 | ||||||
| 2021-09-30 | -$5.27 10-Q · filed 2022-11-10 | -$0.25 10-Q · filed 2021-11-09 | -$23.17 10-Q · filed 2022-11-10 | -$0.97 10-Q · filed 2021-11-09 | ||||
| 2021-06-30 | -$0.29 10-Q · filed 2022-08-03 | -$0.77 10-Q · filed 2022-08-03 | ||||||
| 2021-03-31 | -$0.53 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | -$135.23 10-K · filed 2023-04-17 | -$5.41 10-K · filed 2022-03-29 | ||||||
| 2020-09-30 | -$0.90 10-Q · filed 2021-11-09 | -$4.40 10-Q · filed 2021-11-09 | ||||||
| 2020-06-30 | -$1.37 10-Q · filed 2021-08-05 | -$3.73 10-Q · filed 2021-08-05 | ||||||
| 2019-12-31 | -$11.15 10-K · filed 2022-03-29 | |||||||
| 2017-03-31 | -$5.60 10-Q · filed 2017-05-10 | |||||||
| 2016-12-31 | -$6.84 10-K · filed 2017-03-24 | -$25.56 10-K · filed 2017-03-24 | ||||||
| 2016-09-30 | -$6.58 10-K · filed 2017-03-24 | |||||||
| 2016-06-30 | -$5.70 10-K · filed 2017-03-24 | |||||||
| 2016-03-31 | -$6.42 10-Q · filed 2017-05-10 | |||||||
| 2015-12-31 | -$3.79 10-K · filed 2017-03-24 | -$48.03 10-K · filed 2017-03-24 | ||||||
| 2015-09-30 | -$7.46 10-K · filed 2017-03-24 | |||||||
| 2015-06-30 | -$37.54 10-K · filed 2017-03-24 | |||||||
| 2015-03-31 | -$30.60 10-K · filed 2017-03-24 | |||||||
| 2014-12-31 | -$44.39 10-K · filed 2017-03-24 |